Medicare Enrolled

Dr. Nolan Jenevein, M.D.

Neurology · Dallas, TX
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Speaking/Promotional
6301 GASTON AVE STE 100W, Dallas, TX 75214
2148273610
In practice since 2006 (20 years)
NPI: 1346217163 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jenevein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jenevein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jenevein

Dr. Nolan Jenevein is a neurology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Jenevein performed 712 Medicare services across 266 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jenevein received a total of $25,926 from 50 pharmaceutical and/or device companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jenevein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 39% volume in TX$ $25,926 industry payments

Medicare Practice Summary

Medicare Utilization ↗
712
Medicare services
Top 39% in TX for neurology
266
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)477$25$5,600
Placement of skin electrodes and measurement of stimulated sites on arms and legs59$35$9,700
Measurement of brain wave activity (eeg) outside the brain during surgery51$41$6,496
Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study34$15$3,000
Needle measurement of electrical activity in arm or leg muscles, complete study19$35$38,000
Placement of skin electrodes and measurement of central motor stimulation in arms and legs19$91$9,800
Needle measurement of electrical activity in arm or leg muscles, limited study15$14$30,000
Nerve conduction, 3-4 studies14$50$4,000
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional13$104$4,410
Measurement of brain wave activity (eeg), awake and drowsy11$44$9,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.2% high complexity
3.4% medium
89.5% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$25,926
Total received (2018-2023)
Avg $4,321/year across 6 years
Top 14% in TX for neurology
50
Companies
666
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,501 (63.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,425 (36.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$170
2022
$238
2021
$7,743
2020
$2,865
2019
$6,957
2018
$7,953

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Sunovion Pharmaceuticals Inc.
$12,569
SK Life Science, Inc.
$6,275
NEUROPACE, INC.
$1,177
GENZYME CORPORATION
$469
Genentech USA, Inc.
$449
Supernus Pharmaceuticals, Inc.
$431
UCB, Inc.
$386
Eisai Inc.
$356
Novartis Pharmaceuticals Corporation
$348
LivaNova USA, Inc.
$300
Acorda Therapeutics, Inc
$262
ABBVIE INC.
$241
Allergan Inc.
$208
AbbVie Inc.
$200
Biogen, Inc.
$181
EMD Serono, Inc.
$174
EISAI INC.
$153
NeuroPace, Inc.
$143
Upsher-Smith Laboratories LLC
$141
Amgen Inc.
$128
Allergan, Inc.
$127
PFIZER INC.
$126
ACADIA Pharmaceuticals Inc
$126
Penumbra, Inc.
$122
Avanir Pharmaceuticals, Inc.
$95
Mitsubishi Tanabe Pharma America, Inc.
$63
Horizon Therapeutics plc
$59
Teva Pharmaceuticals USA, Inc.
$52
Grifols USA, LLC
$52
Alexion Pharmaceuticals, Inc.
$48
Merz North America, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$40
Assertio Therapeutics, Inc.
$39
Amneal Pharmaceuticals LLC
$37
Ipsen Biopharmaceuticals, Inc
$34
Greenwich Biosciences, Inc.
$28
Kyowa Kirin, Inc.
$27
AbbVie, Inc.
$22
Merz Pharmaceuticals, LLC
$19
Lundbeck LLC
$19
Almatica Pharma LLC
$18
CATALYST PHARMACEUTICALS, INC.
$18
Impax Laboratories, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Medtronic USA, Inc.
$17
Biohaven Pharmaceuticals, Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$15
GE HEALTHCARE
$15
Lilly USA, LLC
$12
Neurocrine Biosciences, Inc.
$11
Top 3 companies account for 77.2% of total payments
Associated products mentioned in payments ›
AIMOVIG · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · Cambia · DUOPA · Dysport · EMGALITY · Epidiolex · FABRY-DISEASE · FIRDAPSE · Fycompa · GILENYA · Gamunex-C · Gralise · INBRIJA · INGREZZA · KYNMOBI · LEADPOINT · LEMTRADA · LUMIZYME · LYRICA · MAYZENT · Mavenclad · NAPRELAN · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · None · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · OXTELLAR XR · PANZYGA · POMPE - DISEASE · Penumbra System · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RNS Neurostimulator Kit · RNS System · RYTARY · Radicava · Rebif · SOLIRIS · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VERCISE · VNS - Sentiva · VNS Therapy · Vimpat · XCOPRI · XEOMIN · Xeomin · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $3,641 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
235
Per 100K population
9.0
County median income
$74,149
Nearest hospital
WHITE ROCK MEDICAL CENTER
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jenevein is a remote monitoring specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 14%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jenevein experienced with continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)?
Based on Medicare claims data, Dr. Jenevein performed 477 continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jenevein receive payments from pharmaceutical companies?
Yes. Dr. Jenevein received a total of $25,926 from 50 companies across 666 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jenevein's costs compare to other neurologys in Dallas?
Dr. Jenevein's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jenevein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →